Exhibit 99.1
Medicsight and Viatronix
Establish Partnership Agreement
- Provides Viatronix
Customers with Concurrent-Read CAD Technology for
Colon and Lung Cancer Detection -
LONDON AND STONY BROOK, NY, OCTOBER 12,
2005 – Medicsight
PLC, a majority owned subsidiary of
Medicsight, Inc. (OTCBB: MSHT), a leading developer of
computer-aided detection (CAD) technologies and software, and
Viatronix, Inc., a leading innovator and developer of
diagnostic 3D imaging software, announced today the signing of a
non-exclusive partnership agreement to incorporate
Medicsight’s CAD products, Medicsight ColonCAD API and
Medicsight LungCAD API, into Viatronix’s V3D Medical Imaging
Workstations.
The agreement will allow current and new users
of Viatronix’s V3D-Colon and V3D-Explorer modules to add
Medicsight ColonCAD API and LungCAD API image analysis software
tools. Users of the integrated software will be able to
interactively view Medicsight’s ColonCAD polyp identification
marks or LungCAD lung nodule identification marks while viewing a
virtual fly-through of the colon or viewing 3D CT lung images using
real-time volume rendering.
The combined Viatronix / Medicsight imaging
system is expected to reach the market in the fourth quarter of
2005. A pre-release version of V3D-Colon integrated with Medicsight
ColonCAD API will debut at the Sixth International Symposium on
Virtual Colonoscopy next week in Boston. The V3D-Colon system,
along with V3D-Explorer integrated with Medicsight LungCAD API,
will be displayed in its full commercial form at the annual meeting
of the Radiological Society of North America (RSNA) in Chicago, IL
from November 24, 2005 to December 2, 2005.
David Mason, Medicsight USA CEO, commented,
“We are extremely pleased to partner with Viatronix for the
incorporation of our ColonCAD API image analysis software into the
V3D-Colon module. We believe the integration of these two
sophisticated image analysis tools combine to form one of the most
effective colon cancer detection systems available on the market.
In addition, we believe the integration of our LungCAD API image
analysis software into V3D-Explorer will provide radiologists with
an innovative tool for the detection of lung cancer and its
precursors. Support from a leader in advanced medical imaging
systems such as Viatronix demonstrates the revolutionary nature of
our technology. We continue to make progress on our strategy to
deliver clinical excellence in conjunction with strategic partners.
Our software continues to build momentum and wide market acceptance
as the standard in analytical tools for more accurate detection and
treatment of cancer.”
“The integration has been well thought
through and utilizes the full capabilities and strengths of the
Viatronix V3D visualization platform,” said Zaffar Hayat,
Viatronix CEO and President, “Due to the seamless integration
of Medicsight ColonCAD API with the V3D platform, Viatronix
anticipates that Medicsight ColonCAD will be easy to use, require
minimal training, and add greatly to the confidence of the end
user.”
Medicsight CAD tools enable radiologists to read
CT scans of the colon
